Blog

  • Teen Jaloni Hospitalized for Over 475 Days After Gunshot Injury Due to Lack of Safe Housing

    Jaloni, 14, was hospitalized for more than 475 days over three years at SSM Health Cardinal Glennon Children’s Hospital after sustaining a gunshot wound because no suitable safe housing was available for his wheelchair and ongoing care. One stay lasted 250 days.

    Source:KFF Health News · Read original

  • FDA Issues Early Alert on Overheating Risk of Power Cords for Tablo Hemodialysis System

    The FDA issued an early alert regarding the potential risk of overheating at power cord connections for the Tablo Console and TabloCart with prefilter drawer. Affected power cords include PN-0005746 and PN-0008460. Users should check before each use whether the connectors are loose, damaged, or unusually hot, and stop treatment and contact Outset Technical Support if signs of overheating are found.

    Source:FDA · Read Original

  • David Oliver: Learning to Take Risks Is Essential to Medical Practice, but the Context Has Changed Significantly

    In his inaugural lecture at the BMJ and the Academy of Medical Sciences, England’s Chief Medical Officer Chris Whitty argued that doctors should receive systematic training in making and taking responsibility for clinical decisions under uncertainty. He believes this capability should be developed progressively during postgraduate medical training, but in recent years responsibility for risk has often shifted suddenly to senior doctors, increasing their cognitive burden.

    Source:BMJ · Read Original

  • Trump Administration Approves Medicaid Coverage of Indigenous Traditional Therapies in Two States

    The U.S. Department of Health and Human Services approved Utah and Maine to cover Native American traditional healing programs through Medicaid waivers, bringing the number of states with such waivers to six. Covered services include sweat lodge ceremonies and canoe trips, and Utah also designated urban Indian health organizations as qualified providers, although CMS did not approve 100% federal reimbursement for them. California’s waiver is set to expire at the end of December, while its renewal application remained under consideration as of early November.

    Source:KFF Health News · Read original

  • U.S. HHS Updates HIPAA Privacy Rules, Clarifying Health Record Sharing and Personal Health App Standards

    The U.S. Department of Health and Human Services (HHS) has updated the HIPAA Privacy Rules, shortening the maximum time regulated entities have to respond to patients’ requests for their records from 30 days to 15 days. The new rules prohibit unreasonable identity verification requirements and establish standards for “personal health apps” accessing health records, including health apps and connected fitness trackers.

    Source:STAT · Read Original

  • Liz Saunders Receives 2026 BGS Special Medal

    Liz Saunders has been awarded the 2026 BGS Special Medal for her work supporting older people’s care and quality of life at Independent Age. She is one of 12 advisers in the organisation’s telephone advice and support service, helping older people increase their income, claim relevant benefits and access entitled support, with a particular focus on those who are unfamiliar with computers or unable to use them.

    Source:The British Geriatrics Society (BGS) · Read Original

  • Wistar Institute Research Finds That Fructose Can Promote the Spread of Ovarian Cancer Cells

    Researchers at the Wistar Institute published a study in Nature Aging showing that ovarian cancer cells that survive chemotherapy can release fructose as a signal, prompting nearby cancer cells to detach from their original location and spread. In preclinical models, the researchers found that fructose reduces cholesterol production in nearby cancer cells and weakens connections between cells. The individual effects of high fructose intake and statin drugs such as simvastatin still require further study in patients.

    Source:ScienceDaily · Read the original article

  • FDA Approves Sunharbo to Prevent Stroke in Certain High-Risk Adults

    The FDA has approved Bayer HealthCare Pharmaceuticals Inc.’s Sunharbo (asundexian) 50 mg tablets for use in combination with antiplatelet therapy to reduce the risk of stroke in adults with a recent mild-to-moderate non-cardioembolic ischemic stroke or high-risk transient ischemic attack.

    Source:FDA · Read original

  • Belonging to Everyone Yet to No One

    Stroke and geriatrics consultant Dr Sreeman Andole points out that patients may go unassessed when transferred between wards if neither side confirms the handover. She argues that the receiving team should proactively accept the transfer and record a timestamp. She emphasizes that the original team remains responsible until the documentation is complete and that wards should not rely solely on interns’ memory and reminders to identify missed handovers.

    Source:The British Geriatrics Society (BGS) · Read the original

  • HKUMed Study: Nitrogen-Containing Bisphosphonate Users Have 24% Lower Dementia Risk

    Researchers from the University of Hong Kong’s Li Ka Shing Faculty of Medicine analyzed electronic medical records of more than 120,000 patients aged 60 and older between 2005 and 2020. They found that users of nitrogen-containing bisphosphonates had a 16% lower risk of Alzheimer’s disease and related dementias than patients who had not received osteoporosis treatment. Compared with other osteoporosis medications, nitrogen-containing bisphosphonates were associated with a 24% lower risk of dementia, with stronger associations among women and patients with hip fractures. The researchers estimated that treating 48 people continuously for five years could prevent one case of dementia. However, this observational study cannot prove that the medication directly prevents dementia, and further research is needed to determine its actual impact on cognitive decline.

    Source:ScienceDaily · Read the original